Moreover, melatonin could effectively reduce brain inflammation by inhibiting nuclear factor kappa B (NF-κB) translocation and matrix metallopeptidase-9 (MMP-9) activation in lipopolysaccharide (LPS)-induced inflammation in both in vivo and in vitro experimental models (Chang et al., 2012). Here, MMP9 is linked to inflammation.